NCT05481762

Brief Summary

contextflow DETECT Lung CT is a Artificial Intelligence (AI)-based computed-aided detection (CADe) system, intended to support radiologists in the detection of lung nodules in chest computed tomography (CT) scans. System is intended to be used as a second-reader, therefore results provided by the software are meant to complement the radiologist's findings and decisions. Proposed study will be multi-reader, multi case (MRMC) retrospective reader study. The goal of the study is to evaluate the influence of CADe on the effectiveness of lung nodule detection. During the study, 10 radiologists will analyze 350 chest CT scans of adult patients, with and without the assistance of CADe. The study will be conducted remotely. CT scans will be uploaded to a web-based image submission and annotation platform, in which every participant of the study will be provided with individual account and assigned task list. The primary objective of the study determine if the diagnostic accuracy of radiologists with CADe assistance is superior to the diagnostic accuracy of radiologists without CADe assistance in localizing the pulmonary nodules with enhanced area under the free-response operating characteristic curve (AUC of FROC). The study will target approximately 350 asymptomatic adult patients, whose CT scans were acquired during routine CT examination. The patient population will include patients with and without lung nodules.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
337

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2022

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

July 28, 2022

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 1, 2022

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2022

Completed
Last Updated

February 8, 2023

Status Verified

February 1, 2023

Enrollment Period

7 months

First QC Date

July 28, 2022

Last Update Submit

February 7, 2023

Conditions

Keywords

pulmonary noduleartificial intelligencecomputer-aided detection

Outcome Measures

Primary Outcomes (1)

  • Diagnostic accuracy

    The primary objective of the reader study is to determine if the diagnostic accuracy of radiologists with CADe assistance is superior to the diagnostic accuracy of radiologists without CADe assistance in localizing the pulmonary nodules with enhanced area under the free-response operating characteristic curve (AUC of FROC). The true positive rate (or sensitivity) is calculated as the identified positive lesion among the true positive divided by the total number of true positive lesions among all images. The number of false positive findings is collected per image.

    20 hours

Secondary Outcomes (2)

  • Disease diagnosis capabilities

    20 hours

  • Disease identification capabilities

    20 hours

Study Arms (1)

Asymptomatic adult patients

Device: Aided read with contextflow DETECT Lung CT

Interventions

Radiologists read chest CT scabs with and without the aid of contextflow DETECT Lung CT as a second reader

Asymptomatic adult patients

Eligibility Criteria

Age22 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Asymptomatic adult patients (aged 22 or older), with or without pulmonary nodules detected during the routine chest CT scan. CT images taken with CT scanners provided by 3 different vendors, with 50% of images acquired from the US medical centers.

You may qualify if:

  • adult asymptomatic patients, who undergo a routine chest CT scan.

You may not qualify if:

  • symptomatic patients.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

contextflow GmbH

Vienna, 1050, Austria

Location

Related Publications (3)

  • Hansell DM, Bankier AA, MacMahon H, McLoud TC, Muller NL, Remy J. Fleischner Society: glossary of terms for thoracic imaging. Radiology. 2008 Mar;246(3):697-722. doi: 10.1148/radiol.2462070712. Epub 2008 Jan 14.

    PMID: 18195376BACKGROUND
  • Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.

    PMID: 33538338BACKGROUND
  • Qian F, Yang W, Chen Q, Zhang X, Han B. Screening for early stage lung cancer and its correlation with lung nodule detection. J Thorac Dis. 2018 Apr;10(Suppl 7):S846-S859. doi: 10.21037/jtd.2017.12.123.

    PMID: 29780631BACKGROUND

Related Links

MeSH Terms

Conditions

Lung Neoplasms

Condition Hierarchy (Ancestors)

Respiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract Diseases

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 28, 2022

First Posted

August 1, 2022

Study Start

April 1, 2022

Primary Completion

October 30, 2022

Study Completion

October 30, 2022

Last Updated

February 8, 2023

Record last verified: 2023-02

Data Sharing

IPD Sharing
Will not share

In this study, anonymized cases are used. There is no clear connection to patients or IPD included. The identification of cases selected for the study, as well as individual analyzes between readers will be blinded to readers.

Locations